ABT ASSOCIATES NAMES ROSLYN M. BROCK CHIEF GLOBAL EQUITY OFFICER NAACP Chairman Emeritus and Health Equity Advocate
April 21, 2021 11:58 ET | Source: Abt Associates Abt Associates Rockville, Maryland, UNITED STATES
Rockville, Md., April 21, 2021 (GLOBE NEWSWIRE) Abt Associates today named Roslyn M. Brock, a nationally recognized civil rights, health policy, and equity advocate, as its Chief Global Equity Officer. Brock is Chairman Emeritus of the National Board of Directors for the National Association for the Advancement of Colored People (NAACP). She was the youngest person ever elected NAACP chairman and the fourth woman to hold the position.
“Over the past year, we have strengthened our commitment to equity, and Roslyn Brock has dedicated her career to improving equity and opportunity for all,” said Abt Associates President and CEO Kathleen Flanagan. “She is a widely honored social justice c
Breaking the Cycle of Bias That Works Against Women Leaders mit.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mit.edu Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Arcellx Announces Executive Appointments
Arcellx, Inc.April 19, 2021 GMT
GAITHERSBURG, Md., April 19, 2021 (GLOBE NEWSWIRE) Arcellx, a privately held clinical-stage biopharmaceutical company, today announced that it has hired two new executives to join the company’s leadership team. Dr. Christopher Heery has been named Chief Medical Officer (CMO) where he will have responsibility for clinical, regulatory and medical affairs and Neeraj Teotia has been named Chief Commercial Officer where he will have responsibility for marketing, sales, and health economics and reimbursement.
“We are excited to strengthen our leadership team with the additions of Chris and Neeraj as they bring significant expertise to Arcellx and reflect our values and culture. They will lead two critically important areas advancing our clinical programs to meet all requirements for regulatory approvals and ensu
Published: Apr 19, 2021
GAITHERSBURG, Md., April 19, 2021 (GLOBE NEWSWIRE) -Arcellx Inc. a privately held clinical-stage biopharmaceutical company, today announced that it has hired two new executives to join the company’s leadership team. Dr. Christopher Heery has been named Chief Medical Officer (CMO) where he will have responsibility for clinical, regulatory and medical affairs and Neeraj Teotia has been named Chief Commercial Officer where he will have responsibility for marketing, sales, and health economics and reimbursement.
“We are excited to strengthen our leadership team with the additions of Chris and Neeraj as they bring significant expertise to Arcellx and reflect our values and culture. They will lead two critically important areas advancing our clinical programs to meet all requirements for regulatory approvals and ensuring successful commercialization post approval,” said Rami Elghandour, Chairman and Chief Executive Officer of Arcellx. “Chris will le
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Beghou Consulting Promotes Nine Consultants to Partner Across Five U.S. Offices
April 14, 2021 GMT
Since 1993, Beghou Consulting has helped life sciences companies – especially emerging pharmaceutical companies – establish and manage commercial operations to better market and sell therapies. Deploying advanced analytics and proprietary technology, Beghou has counseled the top pharma companies in the world and supported some since infancy. (PRNewsfoto/Beghou Consulting)
Since 1993, Beghou Consulting has helped life sciences companies – especially emerging pharmaceutical companies – establish and manage commercial operations to better market and sell therapies. Deploying advanced analytics and proprietary technology, Beghou has counseled the top pharma companies in the world and supported some since infancy. (PRNewsfoto/Beghou Consulting)